IL25379A - 4,7alpha-dimethyl-(19-nor)-androst-4-enes and 4(alpha and beta)7alpha-dimethyl-(19-nor)-5(alpha and beta)androstanes - Google Patents

4,7alpha-dimethyl-(19-nor)-androst-4-enes and 4(alpha and beta)7alpha-dimethyl-(19-nor)-5(alpha and beta)androstanes

Info

Publication number
IL25379A
IL25379A IL25379A IL2537966A IL25379A IL 25379 A IL25379 A IL 25379A IL 25379 A IL25379 A IL 25379A IL 2537966 A IL2537966 A IL 2537966A IL 25379 A IL25379 A IL 25379A
Authority
IL
Israel
Prior art keywords
7alpha
beta
alpha
dimethyl
androstanes
Prior art date
Application number
IL25379A
Other languages
English (en)
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of IL25379A publication Critical patent/IL25379A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J75/00—Processes for the preparation of steroids in general

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL25379A 1965-04-07 1966-03-14 4,7alpha-dimethyl-(19-nor)-androst-4-enes and 4(alpha and beta)7alpha-dimethyl-(19-nor)-5(alpha and beta)androstanes IL25379A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US446418A US3357888A (en) 1965-04-07 1965-04-07 4, 7-dimethyl androstene derivatives

Publications (1)

Publication Number Publication Date
IL25379A true IL25379A (en) 1969-12-31

Family

ID=23772496

Family Applications (1)

Application Number Title Priority Date Filing Date
IL25379A IL25379A (en) 1965-04-07 1966-03-14 4,7alpha-dimethyl-(19-nor)-androst-4-enes and 4(alpha and beta)7alpha-dimethyl-(19-nor)-5(alpha and beta)androstanes

Country Status (9)

Country Link
US (1) US3357888A (US20110232667A1-20110929-C00004.png)
BE (1) BE679214A (US20110232667A1-20110929-C00004.png)
CH (1) CH485694A (US20110232667A1-20110929-C00004.png)
DE (1) DE1593616A1 (US20110232667A1-20110929-C00004.png)
ES (1) ES325136A1 (US20110232667A1-20110929-C00004.png)
FR (1) FR5802M (US20110232667A1-20110929-C00004.png)
GB (3) GB1147802A (US20110232667A1-20110929-C00004.png)
IL (1) IL25379A (US20110232667A1-20110929-C00004.png)
NL (1) NL6604701A (US20110232667A1-20110929-C00004.png)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5656621A (en) * 1983-08-02 1997-08-12 Research Corporation Tech., Inc. Steroids useful as anti-cancer and anti-obesity agents
GR80020B (en) * 1983-08-02 1984-12-11 Research Corp Steroids useful as anti-cancer,anti-obesity,anti-hyperglycemic, anti-autoimmune and anti-hypercholesterolemic agents
US5804576A (en) * 1983-08-02 1998-09-08 Research Corporation Technologies, Inc. Derivatives of 5-androsten-17-ones and 5-androstan-17-ones
US5714481A (en) * 1983-08-02 1998-02-03 Research Corporation Technologies, Inc. Derivatives of 5-androsten-17 ones and 5-androstan-17-ones
US4898694A (en) * 1987-11-25 1990-02-06 Schwartz Arthur G 17-Hydroxy-steroids
US20070129282A1 (en) * 1998-11-24 2007-06-07 Ahlem Clarence N Pharmaceutical treatments and compositions
US6667299B1 (en) * 2000-03-16 2003-12-23 Hollis-Eden Pharmaceuticals, Inc. Pharmaceutical compositions and treatment methods
AU7736300A (en) 1999-09-30 2001-04-30 Hollis-Eden Pharmaceuticals, Inc. Therapeutic treatment of androgen receptor driven conditions
WO2006110172A2 (en) * 2004-09-29 2006-10-19 Hollis-Eden Pharmaceuticals.Inc. Steroid analogs and characterization and treatment methods

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3076822A (en) * 1958-11-19 1963-02-05 British Drug Houses Ltd 4-methyl-3-oxo-delta steroids and methods for preparing same
US3257431A (en) * 1963-10-04 1966-06-21 Syntex Corp Dichloro and difluoroacetates of substituted testosterone derivatives

Also Published As

Publication number Publication date
GB1147802A (en) 1969-04-10
ES325136A1 (es) 1967-02-16
US3357888A (en) 1967-12-12
CH485694A (de) 1970-02-15
GB1147801A (en) 1969-04-10
BE679214A (US20110232667A1-20110929-C00004.png) 1966-10-07
GB1147803A (en) 1969-04-10
FR5802M (US20110232667A1-20110929-C00004.png) 1968-02-19
NL6604701A (US20110232667A1-20110929-C00004.png) 1966-10-10
DE1593616A1 (de) 1970-12-03

Similar Documents

Publication Publication Date Title
IL25379A (en) 4,7alpha-dimethyl-(19-nor)-androst-4-enes and 4(alpha and beta)7alpha-dimethyl-(19-nor)-5(alpha and beta)androstanes
CA785274A (en) (OPTIONALLY 17-HYDROCARBON-SUBSTITUTED) 11,13.beta.-DIALKYLGON-4-EN-3-ONES AND 5(10)-DEHYDRO COMPOUNDS CORRESPONDING
IL25391A (en) 7alpha-methyl-(19-nor)-androst-4-enes
CA944759A (en) 16.beta.-DIFLUOROMETHYL AND 16-DIFLUOROMETHYLENE STEROIDS AND PROCESSES FOR THEIR PREPARATION
CA706899A (en) PREGNANE AND ALLOPREGNANE-3.beta.,16.alpha.-DIOL-20-ONES
CA717081A (en) 18-NOR 13.beta.-N-PROPYL ESTRONE
CA695204A (en) 17.alpha.-ACYLOXY-6.alpha.-METHYLPREGN-4-ENE-3:20-DIONES AND PROCESS FOR THEIR PREPARATION
CA712598A (en) 6.alpha.-FLUORO-11.beta.,17.alpha.,21-TRIHYDROXY-16.beta.-METHYL-4-PREGNENE-3,20-DIONE
CA743097A (en) 16.alpha.-ETHYNYL-16.beta.-HYDROXY-STEROIDS OF THE ANDROSTANE SERIES AND PROCESS FOR THEIR PREPARATION
CA594708A (en) TESTOSTERONE-17.alpha.-METHYL-11.beta.-OL AND THE 19-NOR DERIVATIVES
CA717077A (en) 3-AMINO-.DELTA.1,3,5(10)-ESTRATRIENE-17.beta.-OL AND THE 17-ACETATE THEREOF
CA737926A (en) .DELTA.4 AND .DELTA.5 DERIVATIVES OF 17.alpha.-ALKENYL- AND 17.alpha.-ALKYNYL-17.beta.-OXYGENATED-2-OXA-5.alpha.-ANDROSTAN-3-ONES, AND 19-NOR COMPOUNDS CORRESPONDING
CA738406A (en) 6.alpha.-METHYL-1,4-ANDROSTADIENE-11.beta.-OL-3,17-DIONE
CA717076A (en) 6.alpha.-METHYL-9.alpha.-FLUORO-11.beta.,17.alpha.-DIHYDROXY-1,4-PREGNADIENE-3,20-DIONE
CA748876A (en) 2-HYDROXYMETHYL-ANDROSTAN-17.beta.-OL-3-ONE, ITS ESTERS AND ITS 19-NOR AND 17.alpha.-HYDROCARBON DERIVATIVES
CA594743A (en) 11.beta.,17.beta.-DIHYDROXY-17.alpha.-ALKYLANDROSTANE-3-ONES, THEIR 19-NOR DERIVATIVES, AND THE MONO- AND DI-ACYLATES THEREOF
CA594744A (en) 17.alpha.-METHYLANDROSTANE-3,11-DIONE-17.beta.-OL, 17-ACYLATE AND ITS 19-NOR DERIVATIVES
CA761435A (en) 2.alpha.-METHYL-9.alpha.-FLUORO-11.beta.,17.alpha.-DIHYDROXY-4-PREGNENE-3,20-DIONE 17-ACYLATE AND PROCESS
CA735427A (en) 11,17.alpha.,21-TRIHYDROXY-9.beta.,10.alpha.-PREGN-4-EN-3,20-DIONE AND METHODS FOR THEIR MANUFACTURE
CA738399A (en) 9.alpha.-HALOGENO-11.beta.-ACYLOXY STEROIDS AND PROCESS FOR THEIR MANUFACTURE
CA709814A (en) 6.alpha. - FLUORO - 11.beta.,17.alpha.,21 - TRIHYDROXY - 16.beta.-METHYL-1,4-PREGNADIENE-3,20-DIONES
CA747902A (en) 16.beta.-ALKYL-3.alpha.-HYDROXY-17-ISOPREGNANE-11,20-DIONE
CA594742A (en) 17.alpha.-ALKYL-ANDROSTANE-3,11.beta.,17.beta.-TRIOLS AND THEIR 19-NOR COMPOUNDS
CA733953A (en) 11.beta.:18-OXIDO STEROIDS
CA732603A (en) 16.beta.-METHYL-17.alpha.-HYDROXY-20-OXO-STEROIDS OF THE PREGNANE-SERIES AND PROCESS